It was a pleasure to talk with Dr Ronald Strauss (Cleveland Allergy and Asthma Center; Case Western Reserve University Medical School, Cleveland, OH, USA) around his article exploring the use of intranasal corticosteroids in the prevention and/ or treatment of COVID-19.
Questions
- What is known about the major ports of entry for the SARS-CoV-2 virus? (0:19)
- What was the rationale for your study? (0:42)
- Could you tell us a little about the study design and findings? (2:30)
- What are the clinical implications of these findings? (4:26)
- What further data are needed before intranasal corticosteroids can be recommended to prevent or treat COVID-19? (5:04)
Citation: Strauss R, Jawhari N, Attaway AH et al. Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019. The Journal of Allergy and Clinical Immunology: In Practice. 2021;9: P3934-3940.E9.
Disclosures: Ronald Strauss has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
